Latest Breaking News On - Analyst tessa romero - Page 1 : comparemela.com

This under-the-radar biotech is targeting genetic heart disorders with gene therapies could boost its stock price by 82%, according to JPMorgan.

Tessa romeroLexeo therapeuticsAnalyst tessa romeroLexeo therapeuticInvestment strategyStock marketsLexeo therapeutics incBusiness news